SKP2 and leukemia: MLL fusion proteins are resistant to ubiquitin‐proteasome‐mediated degradation due to the diminished interactions with E3 ligases Skp2 and Cdc20,37 leading to the stabilization and onset for MLL‐rearranged leukaemia.